Genpact Recognized as a Leader in Life Sciences Regulatory and Medical Affairs in 2024 Everest Group PEAK Matrix® Assessment

Rhea-AI Summary

Genpact (NYSE: G) has been recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® assessment for 2024. This ranking highlights Genpact's outstanding global delivery and AI capabilities, including advanced digital solutions across the regulatory and medical affairs value chain.

Key factors contributing to Genpact's leadership position include:

• Comprehensive suite of digital solutions
• Strategic partnerships with companies like AWS and Veeva
• Cutting-edge AI capabilities, such as Health Agency Q&A and Marketing Authorization Supply Transfer
• Strong presence in the medical technology space
• Expertise in key opinion leader engagement and medical science liaison support

The recognition underscores Genpact's commitment to delivering innovative AI solutions supported by deep industry expertise to clients worldwide in the complex global regulatory environment.

Ranking highlights Genpact's outstanding global delivery and AI capabilities, including advanced digital and AI solutions across regulatory and medical affairs value chain

NEW YORK, July 30, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, has been recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® assessment for 2024.

As stated in the Everest Group report, Genpact earned this distinction due to its comprehensive suite of digital solutions, strategic partnerships with companies such as AWS and Veeva, and cutting-edge AI capabilities. Everest Group also highlighted notable Genpact digital and AI solutions:

• Health Agency Q&A, which uses generative AI and Natural Language Processing (NLP) to automate responses to health authority inquiries, and
  
  
• Marketing Authorization Supply Transfer, which enables integrated planning and tracking of regulatory and supply milestones with built-in business algorithms and regulatory intelligence.

"In today's complex global regulatory environment, enterprises need partners to navigate regulations, drive AI innovation, and achieve speed to market, safety, and compliance," said Sanjiv Tandon, Global Business Leader, Life Sciences, Genpact. "Being recognized as a top-three leader in life sciences underscores our commitment to delivering innovative AI solutions, supported by deep industry expertise, to our clients worldwide."

The report also acknowledged Genpact's strong presence in the medical technology space, highlighting Genpact's expertise in key opinion leader engagement and medical science liaison support, both of which ensure clients receive top-tier consultation and operational support.

"Life sciences enterprises face challenges such as navigating complex compliance systems, adapting to shifting regulations, and meeting diverse regional standards," said Lloyd Fernandes, Life Sciences Practice Director, Everest Group. "As a result, there is increasing reliance on external service providers for deep expertise and advanced technology. Genpact is well-positioned to meet these needs, offering comprehensive services across regulatory affairs. Its ability to integrate deep domain expertise with robust digital solutions to automate regulatory tasks and enhance compliance processes is highly regarded by clients."

Visit here for more information about Genpact's life science solutions and services.

About Genpact
Genpact (NYSE: G) is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose – the relentless pursuit of a world that works better for people – we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI.  

Get to know us at genpact.com and on LinkedIn, X, YouTube, and Facebook.  

MEDIA CONTACT:

Sue Martenson
Genpact Media Relations
susan.martenson@genpact.com
+1 978.905.9582

View original content to download multimedia:https://www.prnewswire.com/news-releases/genpact-recognized-as-a-leader-in-life-sciences-regulatory-and-medical-affairs-in-2024-everest-group-peak-matrix-assessment-302210115.html

SOURCE Genpact Ltd.

FAQ

What recognition did Genpact (G) receive in the 2024 Everest Group PEAK Matrix® Assessment?

Genpact (NYSE: G) was recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® assessment for 2024.

What key factors contributed to Genpact's (G) leadership position in the 2024 Everest Group assessment?

Genpact's leadership position was due to its comprehensive digital solutions, strategic partnerships with AWS and Veeva, cutting-edge AI capabilities, strong presence in medical technology, and expertise in key opinion leader engagement and medical science liaison support.

What specific AI solutions did Everest Group highlight for Genpact (G) in the 2024 assessment?

Everest Group highlighted two notable Genpact AI solutions: Health Agency Q&A, which uses generative AI and NLP to automate responses to health authority inquiries, and Marketing Authorization Supply Transfer, which enables integrated planning and tracking of regulatory and supply milestones.

How does Genpact (G) address the challenges faced by life sciences enterprises according to the 2024 Everest Group report?

Genpact addresses challenges by offering comprehensive services across regulatory affairs, integrating deep domain expertise with robust digital solutions to automate regulatory tasks and enhance compliance processes.